Presentation THT 2022 The Role of the Neutrophil to Lymphocyte Ratio as a Predictor of Late Gadolinium Enhancement on Cardiac MRI in Patients With HFpEF Presenter: Amit Jhaveri February 01, 2022
Presentation THT 2022 Recovered EF Heart Failure -- Physiology, Clinical Implications, and Treatment Presenter: Douglas L. Mann February 01, 2022
Presentation THT 2022 Key Note Address: When Pigs Fly, How Will Drugs, Devices, and Technologies Enhance the Care of Heart Failure Patients? Presenter: Douglas L. Mann February 01, 2022
Presentation THT 2022 REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results Presenter: Sanjiv J. Shah February 01, 2022
Presentation THT 2022 Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF Presenter: Sanjiv J. Shah February 01, 2022
Presentation THT 2022 Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF Presenter: Sanjiv J. Shah February 01, 2022
Presentation THT 2022 Welcome to "Technologies for Heart Failure Therapeutics" Presenter: Daniel Burkhoff February 01, 2022
Presentation THT 2022 Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Evaluating clinical findings to support earlier diagnosis and management Presenter: Gregg Lanier February 01, 2022